TROPIC

About this trial

A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Subjects With Metastatic or Locally Advanced Unresectable Urothelial Cancer

Patient Profile

This Trial is for patients with Metastatic or Locally Advanced Unresectable Urothelial Cancer

Where’s this trial being run?

Tallaght University Hospital and University Hospital Waterford

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.


Summary Data

Name: TROPIC
Number: 21-40
Full Title:

A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Subjects With Metastatic or Locally Advanced Unresectable Urothelial Cancer

Principal Investigator: Prof Ray McDermott
Type: Industry Sponsored
Sponsor:

Gilead Sciences

Recruitment Started: Global: Jan 2021
Ireland: Jul 2022
Global Recruitment Target:
Ireland Recruitment Target: 16